Based on our work during past grant periods, low-frequency sonophoresis (LFS) is now clinically used, but its application is limited to only certain low-molecular weight drugs. To broaden the application of LFS, we aim to improve the treatment regimen of skin using a combination of LFS and the surfactant sodium lauryl sulfate (SLS), as well as to design nano-scale delivery vehicles to be used after LFS/SLS treatment to increase the transdermal delivery of high-molecular weight permeants, such as proteins and vaccines, to therapeutic levels. The proposed studies involve: 1) Understanding the mechanisms of heterogenous skin perturbation with LFS and the observed synergism between LFS/SLS on skin permeability enhancement. These mechanisms will be investigated by studying the cavitation field that develops in the coupling medium between the ultrasound horn and the skin. The synergistic mechanism of LFS/SLS-enhanced transdermal penetration may be identified by correlating the extent of enhanced skin permeability with the partitioning of novel """"""""fluorescent surfactants"""""""" (which allow for molecular-level imaging of surfactant behavior using two-photon fluorescence microscopy) between major skin structural components. Upon determination of these mechanisms, the LFS application and topical formulation may be improved to more effectively deliver drugs through a treated skin area;2) Promoting the formation of """"""""localized transport regions"""""""" (LTRs, highly permeabilized regions that form on the surface of the skin as a result of LFS application) by controlling the nucleation of LFS-induced cavitation events, in order to reduce skin treatment areas, minimize variability between skin treatment sites, and decrease ultrasonic power input requirements;3) Designing polymeric micelle delivery vehicles to enhance the transdermal delivery of permeants through skin pre-treated with LFS/SLS by utilizing functionalized nanoparticles (quantum dots and biomimetic gold nanoparticles) to identify optimal permeant properties for passive transdermal delivery of permeants through skin pre-treated with LFS/SLS;4) Transport modeling of the permeant diffusion pathways through the skin, which will aid in proper clinical drug dosing by predicting the lag time to reach steady state and the steady state permeability of a drug;and 5) Investigating the safety of the LFS/SLS skin treatment by determining the reversibility of the LTRs and their biological effects. Overall, the studies proposed here aim to expand the clinical utility and efficacy of LFS/SLS as a painless and non-invasive method of transdermal drug delivery for a broad class of drugs.
Ultrasound-assisted transdermal drug delivery provides an alternative to oral delivery and injections, circumventing issues related to absorption in the gastrointestinal tract, liver metabolism, and poor patient compliance. The proposed research aims to design a more effective ultrasound-assisted skin treatment regimen in order to deliver a broader class of drugs at therapeutic levels than is currently possible.
|Vegas, Arturo J; Veiseh, Omid; Doloff, Joshua C et al. (2016) Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates. Nat Biotechnol 34:345-52|
|Schoellhammer, Carl M; Traverso, Giovanni (2016) Low-frequency ultrasound for drug delivery in the gastrointestinal tract. Expert Opin Drug Deliv 13:1045-8|
|Vegas, Arturo J; Veiseh, Omid; GÃ¼rtler, Mads et al. (2016) Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med 22:306-11|
|Jhunjhunwala, Siddharth; Alvarez, David; Aresta-DaSilva, Stephanie et al. (2016) Frontline Science: Splenic progenitors aid in maintaining high neutrophil numbers at sites of sterile chronic inflammation. J Leukoc Biol 100:253-60|
|Schoellhammer, Carl M; Schroeder, Avi; Maa, Ruby et al. (2015) Ultrasound-mediated gastrointestinal drug delivery. Sci Transl Med 7:310ra168|
|Veiseh, Omid; Tang, Benjamin C; Whitehead, Kathryn A et al. (2015) Managing diabetes with nanomedicine: challenges and opportunities. Nat Rev Drug Discov 14:45-57|
|Schoellhammer, Carl M; Srinivasan, Sharanya; Barman, Ross et al. (2015) Applicability and safety of dual-frequency ultrasonic treatment for the transdermal delivery of drugs. J Control Release 202:93-100|
|Jhunjhunwala, Siddharth; Aresta-DaSilva, Stephanie; Tang, Katherine et al. (2015) Neutrophil Responses to Sterile Implant Materials. PLoS One 10:e0137550|
|Veiseh, Omid; Doloff, Joshua C; Ma, Minglin et al. (2015) Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nat Mater 14:643-51|
|Schoellhammer, Carl M; Blankschtein, Daniel; Langer, Robert (2014) Skin permeabilization for transdermal drug delivery: recent advances and future prospects. Expert Opin Drug Deliv 11:393-407|
Showing the most recent 10 out of 31 publications